{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T04:55:57Z","timestamp":1789275357202,"version":"build-2803163510"},"reference-count":32,"publisher":"CMA Joule Inc.","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["cmajo"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.9778\/cmajo.20200021","type":"journal-article","created":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T14:32:09Z","timestamp":1614090729000},"page":"E115-E124","source":"Crossref","is-referenced-by-count":19,"title":["Service delivery models for injectable opioid agonist treatment in Canada: 2 sequential environmental scans"],"prefix":"10.9778","volume":"9","author":[{"given":"Erin","family":"Eydt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Glegg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christy","family":"Sutherland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Meador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Trew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Perreault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-\u00c8ve","family":"Goyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Le Foll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Turnbull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Fairbairn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"382","published-online":{"date-parts":[[2021,2,23]]},"reference":[{"key":"2021052814000473000_9.1.E115.1","unstructured":"Special Advisory Committee on the Epidemic of Opioid Overdoses Opioid-related harms in Canada (Public Health Agency of Canada, Ottawa) modified 2020 Sept. 30. Available: https:\/\/health-infobase.canada.ca\/substance-related-harms\/opioids . accessed 2020 June 15."},{"key":"2021052814000473000_9.1.E115.2","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJMp1800216","article-title":"Strategies for reducing opioid-overdose deaths","volume":"378","author":"Wood","year":"2018","journal-title":"N Engl J Med"},{"key":"2021052814000473000_9.1.E115.3","unstructured":"(2019) National injectable opioid agonist treatment for opioid use disorder operational guidance (Canadian Research Initiative in Substance Misuse), Available: https:\/\/crism.ca\/wp-content\/uploads\/2019\/09\/CRISM_National_IOAT_Operational_Guideline-17Sept2019-English-FINAL.pdf . accessed 2019 Dec 7."},{"key":"2021052814000473000_9.1.E115.4","doi-asserted-by":"publisher","DOI":"10.1111\/add.14664"},{"key":"2021052814000473000_9.1.E115.5","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.170958"},{"key":"2021052814000473000_9.1.E115.6","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.110669"},{"key":"2021052814000473000_9.1.E115.7","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.112.111583"},{"key":"2021052814000473000_9.1.E115.8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.330.7503.1297"},{"key":"2021052814000473000_9.1.E115.9","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1111\/add.14171","article-title":"Cost-effectiveness of hydromorphone for severe opioid use disorder: findings from the SALOME randomized clinical trial","volume":"113","author":"Bansback","year":"2018","journal-title":"Addiction"},{"key":"2021052814000473000_9.1.E115.10","doi-asserted-by":"crossref","unstructured":"Ferri M Davoli M Perucci CA (2011) Heroin maintenance for chronic heroin-dependent individuals. Cochrane Database Syst Rev (12):CD003410.","DOI":"10.1002\/14651858.CD003410.pub4"},{"key":"2021052814000473000_9.1.E115.11","unstructured":"Strang J Groshkova T Metrevian N (2012) New heroin-assisted treatment: recent evidence and current practices of supervised injectable heroin treatment in Europe and beyond (European Monitoring Centre for Drugs and Drug Addiction, Lisbon (Portugal))."},{"key":"2021052814000473000_9.1.E115.12","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.114.149195"},{"key":"2021052814000473000_9.1.E115.13","unstructured":"(2017) Guidance for injectable opioid agonist treatment for opioid use disorder (British Columbia Centre on Substance Use and British Columbia Ministry of Health, Vancouver)."},{"key":"2021052814000473000_9.1.E115.14","doi-asserted-by":"crossref","unstructured":"Strang L Taylor J (2018) Heroin-assisted treatment and supervised consumption sites: experience from four countries (RAND Corporation, Santa Monica (CA)).","DOI":"10.7249\/WR1262"},{"key":"2021052814000473000_9.1.E115.15","unstructured":"Leece P Tenanbaum M (2017) Effectiveness of supervised injectable opioid agonist treatment (siOAT) for opioid use disorder [evidence brief] (Public Health Ontario, Toronto)."},{"key":"2021052814000473000_9.1.E115.16","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1001\/jamapsychiatry.2016.0109","article-title":"Hydromorphone compared with diacetylmorphine for long-term opioid dependence: a randomized clinical trial","volume":"73","author":"Oviedo-Joekes","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"2021052814000473000_9.1.E115.17","doi-asserted-by":"crossref","first-page":"606","DOI":"10.17269\/s41997-020-00315-4","article-title":"Expanding access to diacetylmorphine and hydromorphone for people who use opioids in Canada","volume":"111","author":"Maghsoudi","year":"2020","journal-title":"Can J Public Health"},{"key":"2021052814000473000_9.1.E115.18","first-page":"1022","article-title":"Environmental scans: How useful are they for primary care research?","volume":"54","author":"Graham","year":"2008","journal-title":"Can Fam Physician"},{"key":"2021052814000473000_9.1.E115.19","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1016\/j.vaccine.2017.07.080","article-title":"Implementation of HPV vaccination guidelines in a diverse population in Los Angeles: results from an environmental scan of local HPV resources and needs","volume":"35","author":"Baezconde-Garbanati","year":"2017","journal-title":"Vaccine"},{"key":"2021052814000473000_9.1.E115.20","doi-asserted-by":"publisher","DOI":"10.1007\/s10897-018-0262-4"},{"key":"2021052814000473000_9.1.E115.21","unstructured":"(2019) National injectable opioid agonist treatment for opioid use disorder clinical guideline (Canadian Research Initiative in Substance Misuse), Available: https:\/\/crism.ca\/wp-content\/uploads\/2019\/09\/CRISM_National_IOAT_Clinical_Guideline-10Sep2019-English-FINAL.pdf . accessed 2019 Dec 7."},{"key":"2021052814000473000_9.1.E115.22","unstructured":"(2018) Opioid-related harms in Canada [report] (Canadian Institute for Health Information, Ottawa) Available: www.cihi.ca\/sites\/default\/files\/document\/opioid-related-harms-report-2018-en-web.pdf . accessed 2019 Dec 7."},{"key":"2021052814000473000_9.1.E115.23","unstructured":"(2019) Toronto Overdose Information System: deaths (September 2019) (City of Toronto, Toronto) Available: www.toronto.ca\/community-people\/health-wellness-care\/health-inspections-monitoring\/toronto-overdose-information-system\/ . accessed 2019 Dec 7."},{"key":"2021052814000473000_9.1.E115.24","unstructured":"(2010) Atlas on substance use (2010) resources for the prevention and treatment of substance use disorders (World Health Organization, Geneva)."},{"key":"2021052814000473000_9.1.E115.25","unstructured":"(May 15, 2019) Government of Canada approves new treatment options for opioid use disorder and supports research, treatment and harm reduction projects in Ontario [news release] (Health Canada, Ottawa) Available: www.canada.ca\/en\/health-canada\/news\/2019\/05\/government-of-canada-approves-new-treatment-options-for-opioid-use-disorder-and-supports-research-treatment-and-harm-reduction-projects-in-ontario.html . accessed 2019 Dec 7."},{"key":"2021052814000473000_9.1.E115.26","unstructured":"Lovgreen T (Mar 28, 2018) CBC News, Barriers remain for accessing pharmaceutical-grade heroin. Available: www.cbc.ca\/news\/canada\/british-columbia\/heroin-prescription-by-doctors-now-say-drug-users-1.4596170 . accessed 2019 Dec 7."},{"key":"2021052814000473000_9.1.E115.27","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1016\/S2468-2667(19)30040-4","article-title":"Canada\u2019s overdose crisis: authorities are not acting fast enough","volume":"4","author":"Kolla","year":"2019","journal-title":"Lancet Public Health"},{"key":"2021052814000473000_9.1.E115.28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0810635"},{"key":"2021052814000473000_9.1.E115.29","unstructured":"(2017) Overdose data and First Nations in BC: preliminary findings (First Nations Health Authority, West Vancouver (BC))."},{"key":"2021052814000473000_9.1.E115.30","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.181093"},{"key":"2021052814000473000_9.1.E115.31","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1111\/add.14417","article-title":"Gendered violence and overdose prevention sites: a rapid ethnographic study during an overdose epidemic in Vancouver, Canada","volume":"113","author":"Boyd","year":"2018","journal-title":"Addiction"},{"key":"2021052814000473000_9.1.E115.32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.drugpo.2019.05.002","article-title":"Gender and the overdose crisis in North America: moving past gender-neutral approaches in the public health response","volume":"69","author":"Collins","year":"2019","journal-title":"Int J Drug Policy"}],"container-title":["CMAJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.9778\/cmajo.20200021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T21:03:14Z","timestamp":1622235794000},"score":1,"resource":{"primary":{"URL":"http:\/\/cmajopen.ca\/lookup\/doi\/10.9778\/cmajo.20200021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,2,23]]},"published-print":{"date-parts":[[2021,1]]}},"alternative-id":["10.9778\/cmajo.20200021"],"URL":"https:\/\/doi.org\/10.9778\/cmajo.20200021","relation":{},"ISSN":["2291-0026"],"issn-type":[{"value":"2291-0026","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}